Gsa Capital Partners LLP Sangamo Therapeutics, Inc Transaction History

Gsa Capital Partners LLP

$1.11 Billion
Q1 2025

A detailed history of Gsa Capital Partners LLP transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Gsa Capital Partners LLP holds 966,202 shares of SGMO stock, worth $434,790. This represents 0.06% of its overall portfolio holdings.

Number of Shares

966,202

Previous 31,553 2962.16%

Holding current value

$434,790

Previous $32,000 1881.25%

% of portfolio

0.06%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 08, 2025	BUY	$0.66 - $1.37 $616,868 - $1.28 Million	934,649 Added 2962.16%	966,202 $634,000
Q4 2024 Feb 07, 2025	SELL	$0.78 - $2.87 $244,981 - $901,406	-314,079 Reduced 90.87%	31,553 $32,000
Q3 2024 Nov 05, 2024	SELL	$0.32 - $1.1 $188,014 - $646,298	-587,544 Reduced 62.96%	345,632 $299,000
Q2 2024 Aug 15, 2024	BUY	$0.36 - $0.65 $204,801 - $369,779	568,892 Added 156.17%	933,176 $334,000
Q1 2024 May 03, 2024	SELL	$0.42 - $1.38 $298,790 - $981,740	-711,406 Reduced 66.13%	364,284 $244,000
Q4 2023 Feb 16, 2024	BUY	$0.3 - $0.63 $154,787 - $325,054	515,959 Added 92.18%	1,075,690 $580,000
Q3 2023 Nov 15, 2023	SELL	$0.58 - $1.47 $143,389 - $363,417	-247,223 Reduced 30.64%	559,731 $335,000
Q2 2023 Aug 14, 2023	BUY	$1.11 - $1.74 $652,531 - $1.02 Million	587,866 Added 268.32%	806,954 $1.05 Million
Q1 2023 May 12, 2023	BUY	$1.66 - $3.67 $30,914 - $68,346	18,623 Added 9.29%	219,088 $385,000
Q4 2022 Feb 13, 2023	BUY	$2.77 - $5.07 $513,599 - $940,054	185,415 Added 1231.99%	200,465 $629,000
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $33,028 - $49,426	-7,735 Reduced 33.95%	15,050 $74,000
Q2 2022 Aug 09, 2022	SELL	$3.28 - $6.21 $43,273 - $81,928	-13,193 Reduced 36.67%	22,785 $94,000
Q1 2022 May 11, 2022	BUY	$5.23 - $7.82 $188,164 - $281,347	35,978 New	35,978 $209,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $10.97 $235,029 - $353,672	-32,240 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$9.01 - $12.01 $290,482 - $387,202	32,240 New	32,240 $290,000
Q3 2020 Nov 06, 2020	SELL	$9.38 - $12.48 $95,891 - $127,583	-10,223 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$6.21 - $11.83 $63,484 - $120,938	10,223 New	10,223 $92,000
Q1 2020 May 12, 2020	SELL	$5.05 - $8.85 $51,454 - $90,172	-10,189 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$8.03 - $11.7 $81,817 - $119,211	10,189 New	10,189 $85,000
Q2 2019 Aug 06, 2019	SELL	$8.75 - $13.03 $569,021 - $847,353	-65,031 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$7.72 - $12.81 $104,752 - $173,818	-13,569 Reduced 17.26%	65,031 $620,000
Q4 2018 Feb 12, 2019	BUY	$9.51 - $16.6 $747,486 - $1.3 Million	78,600 New	78,600 $902,000
Q2 2018 Aug 09, 2018	SELL	$13.9 - $19.8 $322,771 - $459,775	-23,221 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$16.7 - $26.35 $387,790 - $611,873	23,221 New	23,221 $441,000

Others Institutions Holding SGMO

# of Institutions

137

Shares Held

51.2M

Call Options Held

2.17M

Put Options Held

1.82M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $70.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Sangamo Therapeutics, Inc Transaction History